|
EDUCATIONAL
POLICY COMMITTEE
Thursday,
January 18, 2001
6:15
— 6:25 p.m.
Saturday,
January 20, 2001
9:45 — 10:30 a.m.
Board
Room, The Rotunda
Committee Members:
T. Keister Greer, Chair
Elsie Goodwyn Holland Walter F. Walker
Stephen S. Phelan, Jr. Joseph E. Wolfe
Elizabeth A. Twohy John P. Ackerly, III, Ex Officio
AGENDA
I.
CONSENT AGENDA (Mr. Low) (Thursday)
- Department
Name Changes, School of Engineering and Applied
Science
- Conflict
of Interest Exemption (MonicAid Corporation)
- Fiscal
Impact Statement 5
-
Conflict of Interest Exemption (DVTI, Incorporated)
- Fiscal
Impact Statement 9
II.
REPORTS BY THE VICE PRESIDENT AND PROVOST (Saturday) (Mr. Low)
- Vice
President’s Remarks
- Progress
Report on Virginia 2020 Commissions (Mr. Low to introduce
Ms. Laurie P. Kelsh; Ms.
Kelsh to report)
C.
Faculty Senate (Mr. Low to introduce 13 Ms.
Patricia H. Werhane; Ms. Werhaneto report)
D. Library of Tomorrow (Mr. Low to introduce Ms. Karin
Wittenborg; Ms. Wittenborg toReport)
III. FACULTY PERSONNEL ACTIONS
*
For consideration in Executive Session
UNIVERISTY
OF VIRGINIA
BOARD
OF VISITORS AGENDA ITEM SUMMARY
AGENDA
ITEM: I.A. Department Name Changes, School of Engineering
and Applied Science
BACKGROUND:
The School of Engineering and Applied Science has proposed name
changes for two departments.
DISCUSSION:
We have approved internally the School’s proposal that the
Department of Electrical Engineering be changed to the Department
of Electrical and Computer Engineering, and the Department of Systems
Engineering be changed to the Department of Systems and Information
Engineering. Both changes are being made in order more accurately
to reflect the mission, teaching and research interests of the departments.
We have forwarded this proposal to the State Council of Higher Education,
where it will receive automatic approval from Council staff, as
it will be treated as an item "for purposes of internal management
only."
ACTION
REQUIRED: This item requires no action by the Board. It is on
the Agenda simply as a report to the Board of an action taken.
AGENDA
ITEM: I.B. Conflict of Interest Exemption
(MonicAid Corporation)
BACKGROUND:
The School of Medicine is negotiating a sponsored research contract
with MonicAid Corporation, a Virginia biotechnology company created
on July 28, 2000, to support research aimed at investigating the
protective effect of IgM autoantibodies in retarding development
of AIDS after an HIV-1 infection.
DISCUSSION:
One University faculty member, Peter I. Lobo, M.D., and members
of his family own in excess of three percent of the equity in the
company. Under the Virginia Conflict of Interests Act, the University’s
contracting with MonicAid Corporation would place Dr. Lobo in violation
of the Act, unless the Board of Visitors approves the conflict created
by his and his family members’ equity interest. State law grants
such approval authority to the Board in the case of sponsored research,
in order to allow research furthering the public interest.
Virginia
law and University of Virginia policy will require Dr. Lobo to file
annual disclosure statements of his and his family members’
economic interests in the company. Dr. Lobo will not be involved
in the University’s negotiation, approval, or procurement of
contract terms with MonicAid Corporation. The chair of the Department
of Internal Medicine heads a University oversight team responsible
for managing and overseeing the research, including independently
supervising, evaluating, and making personnel decisions, to ensure
that the continuing best interests of the University are served.
As an additional precaution, the chair will report at least each
quarter to the Dean of the School of Medicine on the progress of
sponsored research activity and the utilization of University resources.
ACTION
REQUIRED: Approval by the Educational Policy Committee and the
Board of Visitors.
UNIVERSITY
OF VIRGINIA
FISCAL
IMPACT STATEMENT
PROJECT/PROPOSED
BOARD OF VISITORS ACTION: Approval to enter into sponsored research
contracts with MonicAid Corporation
DESCRIPTION:
The School of Medicine is negotiating a sponsored research contract
with MonicAid Corporation, a Virgina biotechnology start-up company
created in July 2000. The founding members of MonicAid Corporation
include a University of Virginia faculty member.
One
faculty member and members of his family own a total of 88.5 percent
equity in the company. Under the Virginia Conflict of Interests
Act, the School of Medicine may enter into a research contract with
MonicAid Corporation without placing the faculty member in violation
of the Act, if the Board of Visitors approves the conflict created
by his and his family’s ownership in excess of three percent.
The
research contract would help fund research to investigate the role
of human IgM antibodies to chemokine receptors in HIV and AIDS.
FISCAL
IMPACT: Fiscal impact is negligible.
CONCLUSION:
It is recommended that the Board of Visitors permit the University
to negotiate and enter into the proposed contract with MonicAid
Corporation to investigate the role of human IgM antibodies to chemokine
receptors in HIV and AIDS.
RECOMMEND
APPROVAL OF BOARD ACTION:
__________________________
Leonard
W. Sandridge
January
18, 2001
AGENDA
ITEM: I.C. Conflict of Interest Exemption
(DVTI, Incorporated)
BACKGROUND:
The University of Virginia is negotiating a contract with Directed
Vapor Technologies International, Incorporated (DVTI, Inc.), a Delaware
company created on June 1, 2000 to support commercialization of
University of Virginia technology related to directed vapor deposition
which has been licensed to DVTI, Inc. for commercialization.
DISCUSSION:
Three University faculty members, James Groves, Douglas Queheillalt
and Derek Haas each own in excess of three percent of the equity
in the company. Under the Virginia Conflict of Interests Act, the
University’s contracting with DVTI, Inc. would place all three
in violation of the Act, unless the Board of Visitors approves the
conflict created by their equity interest. State law grants such
approval authority to the Board in the case of contracts which support
commercialization of University intellectual property.
Virginia
law and University of Virginia policy will require James Groves,
Douglas Queheillalt and Derek Haas to file annual disclosure statements
of their economic interests in the company. None of these faculty
will be involved in the University’s negotiation, approval,
or procurement of contract terms with DVTI, Inc. The chair of the
Department of Materials Science and Engineering will head a University
oversight team responsible for managing and overseeing the contract
to ensure that the continuing best interests of the University are
served. As an additional precaution, the chair will report at least
each quarter to the Dean of the School of Engineering and Applied
Science on the progress of the commercialization efforts and the
utilization of University resources.
ACTION
REQUIRED: Approval by the Educational Policy Committee and the
Board of Visitors.
UNIVERSITY
OF VIRGINIA
FISCAL
IMPACT STATEMENT
PROJECT/PROPOSED
BOARD OF VISITORS ACTION: Approval to enter into contracts with
Directed Vapor Deposition International, Incorporated.
DESCRIPTION:
The University of Virginia is negotiating a contract with DVTI,
Incorporated, a Delaware start-up company created in June 2000 to
commercialize University of Virginia intellectual property in the
field of vapor deposition. The Corporation includes three University
of Virginia faculty members.
Each
of the three faculty members owns more than 3 percent equity in
the company. Under the Virginia Conflict of Interests Act, the University
of Virginia may enter into a contract with DVTI, Incorporated without
placing the faculty members in violation of the Act, if the Board
of Visitors approves the conflict created by their ownership in
excess of three percent.
The
contract would reimburse the University for the use of an advanced
vapor deposition device to permit DVTI, Incorporated to test some
commercial samples.
FISCAL
IMPACT: Fiscal impact is negligible. However, successful
commercialization of this technology could provide substantial returns
to the University from royalty income.
CONCLUSION:
It is recommended that the Board of Visitors permit the
University to negotiate and enter into the proposed contract with
DVTI, Incorporated to test samples of commercial materials.
RECOMMEND
APPROVAL OF BOARD ACTION:
__________________________
Leonard
W. Sandridge
January
18, 2001
AGENDA
ITEM: II.A. Vice President’s Remarks
DISCUSSION:
The Vice President and Provost will use this portion of the Educational
Policy Committee to inform the Board of Visitors of recent events
of which the Board should be made aware.
ACTION
REQUIRED: None
AGENDA
ITEM: II.B. Progress Report on Virginia 2020
Commissions
DISCUSSION:
The Vice President and Provost will introduce The University’s
Chief Planning Officer, Ms. Laurie P. Kelsh, who will brief the
Board on the progress of the Virginia 2020 Commissions.
ACTION
REQUIRED: None
AGENDA
ITEM: II.C. Faculty Senate
DISCUSSION:
The Vice President and Provost will introduce the Chair of the Faculty
Senate, Ms. Patricia H. Werhane, who will give a report to the Board
on the Senate’s accomplishments during the fall semester.
ACTION
REQUIRED: None
AGENDA
ITEM: II.D. Library of Tomorrow
DISCUSSION:
The Vice President and Provost will introduce Ms. Karin Wittenborg,
University Librarian, who will give a report to the Board on the
Library of Tomorrow.
ACTION
REQUIRED: None
MORE
MEETING INFORMATION
PAST MEETINGS
PUBLIC
MINUTES
|
